SAVA Q2 2017 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3,063

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.64

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$709,000

Balance Sheet

Total Assets

$14M

Total Liabilities

$999,000

Stockholders' Equity

$13M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3,063	-$1,589	-92.8%
Operating Income	-$4M	-$3M	-36.9%
Net Income	-$4M	-$3M	-38.0%